Zhuang et al. demonstrated that FASN inhibition promotes the radiotherapy sensitization of prostate cancer (both androgen-dependent and -independent) due to inhibition of NF-κB activity.47 However, the underlying mechanism remains unclear. Here, NFKB1 is linked to prostate cancer.